BMJ  2008;336:629-630 (22 March), doi:10.1136/bmj.39520.483565.3A

Letters

Moving beyond depression

How full is the glass?

The first 150 words of the full text of this article appear below.

Instead of speculating about our differing methods as the source of our differing conclusions, Turner and Rosenthal instead focused on our adoption of UK’s National Institute for Health and Clinical Excellence (NICE) criteria for clinical significance. NICE adopted Cohen’s definition of a "medium" effect size (0.5) for clinical significance.1 2 Cohen intended that a medium effect size represent an effect of a size likely to be visible to the naked eye of a careful observer (p 156). By this interpretation, clinical significance of antidepressants is reached when a careful observer can see that medicated patients have noticeably lower depression than patients taking placebo. In this light, the NICE criteria seem sensible indeed.

A more appropriate use of Turner and Rosenthal’s "d-juice" metaphor (where d-juice is the level of antidepressant efficacy) to explain our findings is that the amount of d-juice in the trials was pitifully small or even non-existent when people . . . [Full text of this article]

Irving Kirsch, professor of psychology, Blair T Johnson, professor of psychology

1 University of Hull, Hull HU6 7RX, 2 Department of Psychology and Center for Health, Intervention, and Prevention, University of Connecticut, Storrs, Connecticut, USA

I.Kirsch@hull.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Efficacy of antidepressants
Erick H Turner and Robert Rosenthal
BMJ 2008 336: 516-517. [Extract] [Full Text] [PDF]




Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview